These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19759088)

  • 21. Zinc Deficiency and Intestinal Permeability in the Context of Rational Diagnostic and Drug Development for Diarrhea-Predominant Irritable Bowel Syndrome.
    Shah ED
    Dig Dis Sci; 2022 Aug; 67(8):3477-3478. PubMed ID: 35018534
    [No Abstract]   [Full Text] [Related]  

  • 22. Upper GI symptoms in patients with irritable bowel syndrome.
    Mann NS
    Am J Gastroenterol; 2004 Jun; 99(6):1191; author reply 1192. PubMed ID: 15180743
    [No Abstract]   [Full Text] [Related]  

  • 23. False-positive results from a diagnostic colonoscopy: a teachable moment.
    Sheu L; Gottenborg EW
    JAMA Intern Med; 2014 May; 174(5):665-6. PubMed ID: 24663348
    [No Abstract]   [Full Text] [Related]  

  • 24. Irritable bowel syndrome.
    Bolin TD
    Aust Fam Physician; 2005 Apr; 34(4):221-4. PubMed ID: 15861740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mrs. C.'s chronic abdominal pain].
    Rothen N; Scheidegger S
    Rev Med Suisse; 2007 Jan; 3(93):78-9. PubMed ID: 17354666
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of diarrhea in clinical practice: strategies for primary care physicians.
    Schiller LR
    Rev Gastroenterol Disord; 2007; 7 Suppl 3():S27-38. PubMed ID: 18192963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding and treating an irritable bowel.
    Harv Womens Health Watch; 2004 Apr; 11(8):1-3. PubMed ID: 15100057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective.
    Lewis JH
    Expert Rev Gastroenterol Hepatol; 2010 Feb; 4(1):13-29. PubMed ID: 20136586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Entamoeba species associated with chronic diarrhoea in Pakistan.
    Yakoob J; Abbas Z; Beg MA; Naz S; Khan R; Jafri W
    Epidemiol Infect; 2012 Feb; 140(2):323-8. PubMed ID: 21396144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [42-year-old patient with diarrhea since 6 months].
    Fritzsch J
    Dtsch Med Wochenschr; 2011 Jan; 136(1-2):27-8. PubMed ID: 21181612
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic diarrhoea.
    Spiller R
    Gut; 2007 Dec; 56(12):1756-7. PubMed ID: 17998327
    [No Abstract]   [Full Text] [Related]  

  • 32. Applicability of the reported prevalence of bile salt malabsorption in irritable bowel.
    Ford AC
    Aliment Pharmacol Ther; 2010 Jan; 31(1):161-2; author reply 162-4. PubMed ID: 20002031
    [No Abstract]   [Full Text] [Related]  

  • 33. Is amitriptyline really effective in diarrhoea-predominant irritable bowel syndrome?
    Chassany O; Duracinsky M
    Aliment Pharmacol Ther; 2008 Aug; 28(3):371-2; author reply 372-3. PubMed ID: 19086238
    [No Abstract]   [Full Text] [Related]  

  • 34. Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: The role of nitric oxide pathway.
    Shamshiri H; Paragomi P; Paydar MJ; Moezi L; Bahadori M; Behfar B; Ardalan FA; Dehpour AR
    J Gastroenterol Hepatol; 2009 Apr; 24(4):672-80. PubMed ID: 19032458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome.
    Vahedi H; Merat S; Momtahen S; Kazzazi AS; Ghaffari N; Olfati G; Malekzadeh R
    Aliment Pharmacol Ther; 2008 Apr; 27(8):678-84. PubMed ID: 18248658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.
    Weinland SR; Morris CB; Hu Y; Leserman J; Bangdiwala SI; Drossman DA
    Am J Gastroenterol; 2011 Oct; 106(10):1813-20. PubMed ID: 21647206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between symptoms and motor and visceral sensory responses of irritable bowel syndrome patients to spasmolytics (antispasmodics).
    Khalif IL; Quigley EM; Makarchuk PA; Golovenko OV; Podmarenkova LF; Dzhanayev YA
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):17-22. PubMed ID: 19337628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Enterosan--perspective medications for patients with postinfection irritable bowel syndrome].
    Parfenov AI; Ruchkina IN
    Eksp Klin Gastroenterol; 2011; (3):102-4. PubMed ID: 21695957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of serum chromogranin A in diarrhoea predominant irritable bowel syndrome.
    Sidhu R; McAlindon ME; Leeds JS; Skilling J; Sanders DS
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):23-6. PubMed ID: 19337629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commentary on peripheral and central contributions to hyperalgesia in irritable bowel syndrome.
    Mayer EA
    J Pain; 2006 Aug; 7(8):539-41; discussion 542-3. PubMed ID: 16885009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.